I'd say with the Baker Bro.'s at the helm, it IS different this time, especially now with Tom Klein on board, their new Chief Commercial Officer. "Klein joined Genentech from Roche, where he oversaw hepatology and HIV sales and marketing teams. He also worked at Westwood-Squibb and Bristol Myers-Squibb." I'd say he was well vetted, and Klein clearly saw enormous benefit leaving Roche/Genentech for XOMA's team. This could easily be a 10-bagger from here.